Dichotomic effects of IFN-γ on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice

European Journal of Immunology

Volumn 30, Issue 2, 2000, Pages 438-447

  Nicoletti, Ferdinando ^a,g   Di Marco, Roberto ^b   Zaccone, Paola ^b   Xiang, Ming ^b   Magro, Gaetano ^b   Grasso, Sebastiane ^b   Morrone, Stefania ^c   Santoni, Angela ^c   Shoenfeld, Yehuda ^d   Garotta, Gianni ^e   Meroni, PierLuigi ^f  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SHEBA MEDICAL CENTER   (Israel)

^e Serono International SA   (Switzerland)

^f ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^g NONE   (Italy)

Author keywords

Autoimmune diseases; Cytokine; IFN ; MRL lpr mouse; Systemic lupus erythematosus

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; SINGLE STRANDED DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; INFLAMMATORY INFILTRATE; KIDNEY DISEASE; LUNG DISEASE; LYMPHADENITIS; MORTALITY; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEINURIA; SKIN DISEASE; SPLEEN LYMPHOCYTE; SPLEEN WEIGHT; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; UREMIA; VASCULITIS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; FEMALE; INTERFERON TYPE II; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; RATS;

EID: 0033976316     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200002)30:2<438::AID-IMMU438>3.0.CO;2-D     Document Type: Article

References (37)

1. Cohen, P. L. and Eisenberg, R. A., Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991. 9: 243-269.
2. Handwerger, B. S., Rus, V., da Silva, L. and Via, C. S., The role of cytokines in the immunopathogenesis of lupus. Springer Semin. Immunopathol. 1994. 16: 153-180.
3. Rabinovitch, A., An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 1998. 14: 129-151.
4. Horwitz, D. A., Gray, J. D., Behrendsen, S. C., Kubin, M., Rengaraju, M., Ohtsuka, K. and Trinchieri, G., Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum. 1998. 41: 838-844.
5. Jacob, C. O., Van der Meide, P. H. and McDevitt, H. O., In vivo treatment of (NZB xNZW)F1 lupus-like nephritis with monoclonal antibody to gamma-interferon. J. Exp. Med. 1987. 166: 798-803.
6. Nicoletti, F., Zaccone, P., Magro, G., Barcellini, W., Cavallaro, V., Belli, G., Cocuzza, C., Di Marco, R. and Meroni, P. L., The effects of thymopentin on the development of SLE-like syndrome in the MRL/lpr-lpr mouse. Scand. J. Immunol. 1994. 40: 549-556.
7. Nicoletti, F., Meroni, P. L., Di Marco, R., Barcellini, W., Borghi, M. O., Gariglio, M., Mattina, A., Grasso, S. and Landolfo, S., In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse. Immunopharmacology 1992. 24: 11-16.
8. Horwitz, D. A. and Jacob, C. O., The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications. Springer Semin. Immunopathol. 1994. 16: 181-200.
9. Takahashi, S., Fossati, L., Iwamoto, M., Merino, R., Motta, R., Kobayakawa, T. and Izui, S., Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 1996. 97: 1597-1604.
10. Huang, F.-P., Feng, G.-J., Lindop, G., Stott, D. I. and Liew, F Y., The role of interleukin-12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J. Exp. Med. 1996. 183: 1447-1459.
11. Takahashi, S., Nose, M., Sasaki, J., Yamamoto, T. and Kyogoku, M., IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J. Immunol. 1991. 147: 515-519.
12. Amital, H., Levi, Y., Blank, M., Barak, V., Langevitz, P., Afek, A., Nicoletti, F., Kopolovic, J., Gilburd, B., Meroni, P. L. and Shoenfeld, Y., Immunomodulation of murine experimental SLE-like disease by interferon-γ. Lupus 1998. 7: 445-454.
13. Peng, S. L., Moslehi, J. and Craft, J., Roles of Interferon-γ and interleukin-4 in murine lupus. J. Clin. Invest. 1997. 99: 1936-1946.
14. Balomenos, D., Rumold, R. and Theofilopoulos, A. N., Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 1998. 101: 364-471.
15. lpr mice. J. Immunol. 1996. 161: 494-503.
16. Haas, C., Ryffel, B. and Le Hir, M., IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J. Immunol. 1997. 158: 5484-5491.
17. Fernandes, G. and Good, R. A., Inhibition by restricted-calorie diet of lymphoproliferative disease and renal damage in MRL/llpr mice. Proc. Natl. Acad. Sci. USA 1984. 81: 6144-6148.
18. Xiang, M., Zaccone, P., Di Marco, R., Harris, R., Magro, G., Di Mauro, M., Meroni, P. L., Garotta, G. and Nicoletti, F., Autoimmunity 1999. 29: 71-80.
19. Jacob, C. O., Holoshitz, J., Van Der Meide, P., Strober, S. and McDevitt, H. O., Heterogeneous effects of IFN-gamma in adjuvant arthritis. J. Immunol. 1989. 142: 1500-1505.
20. Boissier, M.-C., Chiocchia, G., Bessis, N., Hajnal, J., Nicoletti, F. and Fournier, C., Biphasic effect of interferon-γ in murine collagen-induce arthritis. Eur. J. Immunol. 1995. 25: 1184-1190.
21. Strigard, K., Holmdahl, R., van der Meide, P., Klareskog, L. and Olsson, T., In vivo treatment of rats with monoclonal antibodies against gamma interferon: effects on experimental allergic neuritis. Acts Neurol. Scand. 1989. 80: 201-207.
22. Abed, N. S., Chace, J. H. and Cowdery, J. S., T cell-independent and T-cell dependent B cell activation increases IFN-gamma R expression and renders B cells sensitive to IFN-gamma-mediated inhibition. J. Immunol. 1994. 153: 3369-3377.
23. Wahl, S. M., Allen, J. B., Ohura, K., Chenoweth, D. E. and Hand, A. R., Interferon-gamma inhibits inflammatory cell recruiment and the evolution of bacterial cell-wall-induced arthritis. J. Immunol. 1991. 146: 95-100.
24. Gajewski, T. and Fitch, F. W., Anti-proliferative effect of IFN-gamma in immune regulation. IV Murine CTL clones produce IL-3 and GM-CSF, the activity of which is masked by the inhibitory action of secreted IFN-gamma. J. Immunol. 1990. 144: 548-556.
25. G-monomethyl-L-arginine. J. Exp. Med. 1994. 179: 651-660.
26. Heremans, H. R., Dijkmans, R., Sobis, H., Vandekerchove, F. and Biliau, A., Regulation by interferons of the local inflammatory response to lipopolisaccharide. J. Immunol. 1987. 138: 4175-4179.
27. lpr autoimmune interstitial nephritis: a negative regulatory pathway. J. Immunol. 1998. 160: 4074-4081.
28. Doncarli, A., Stasui, L. M., Fournier, C. and Abeshira-Amar, O., Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur. J. Immunol. 1997. 27: 1451-1458.
29. van der Meide, P., Groenestein, R. J., De Labie, M. C. D. C., Aten, J. and Weening, J. J., Susceptibility to mercuric chloride-induced glomerulonephritis is age-dependent: study of the role of IFN-gamma. Cell. Immunol. 1995. 162: 131-137.
30. Yokoyama, H., Kreft, B. and Rubin Kelley, V., Biphasic increase in circulating and renal TNF-α in MRL-lpr mice with different regulatory mechanisms. Kidney Int. 1995. 47: 122-130.
31. Manoury-Schwartz, B., Chiochhia, G., Bessis, N., Abeshira-Amar, O., Batteux, F., Muller, S., Huang, S., Boissier, M. C. and Fournier, C., High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J. Immunol. 1997. 158: 5501-5506.
32. Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A. and Matthys, P., Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J. Immunol. 1997. 158: 5507-5513.
33. Le Hir, M., Martin, M. and Haas, C. A., Syndrome resembling human systemic sclerosis (scleroderma) in MRL/lpr mice lacking interferon-gamma (IFN-γ) receptor (MRL/lprγR-/-). Clin. Exp. Immunol. 1999. 115: 281-287.
34. Grasseger, A., Schuler, G., Hessenberger, G., Walder-Hantich, B., Jabkowski, J., MacHeiner, W., Salmhofer, W., Zahel, B., Pinter, G., Herold, M., Klein, G. and Fritsch, P. O., Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial. Br. J. Dermatol 1998. 139: 639-648.
35. Gray, P. W. and Goeddel, D. V., Cloning and expression of murine immune interferon cDNA. Proc. Natl. Acad. Sci. USA 1983. 80: 5842-5846.
36. Van der Meide, P. H., Dubbeld, M., Vijverberg, K., Kos, T. and Schellekens, H., The purification and characterization of of rat gamma interferon by the use of two monoclonal antibodies. J. Gen. Virol. 1986. 67: 1059-1071.
37. Seggev, J. S., Sunderrajan, E. V., Paolomo, T., McKenzie, W. N., Braun, S. R., O'Sullivan, F. X. and Waleker, S. E., Pulmonary perivascular and interstitial inflammation in MRL/MpJ-lpr/lpr mice. Clin. Immunol. Immunopathol. 1991. 60: 289-298.